Immunosuppresion: Clinical Trials

1 trial for Immunosuppresion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Immunosuppresion: new trials by email Literature Review of Immunosuppresion trials Research Report on Immunosuppresion

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Anti-thymocyte globulin (rabbit), Anti-thymocyte globulin (horse), Cyclosporine - Immunosuppresion, Thrombocytopenia
Phase 2CompletedNational Heart, Lung, and Blood Institute (NHLBI)1362005-11-282017-06-08

Narrower conditions

Anemia, Aplastic (1)  ·  Autoimmune Diseases (1)  ·  Neutropenia (1)  ·  Pancytopenia (1)  ·  Thrombocytopenia (1)

Broader conditions

Agranulocytosis (1)  ·  Anemia (1)  ·  Blood Platelet Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Failure Disorders (1)  ·  Cytopenia (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Leukocyte Disorders (1)  ·  Leukopenia (1)

Interventions

Alemtuzumab (1)  ·  Antilymphocyte Serum (1)  ·  Cyclosporine (1)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (1)

Countries

United States (1)

Top investigators

Danielle M Townsley, M.D. (1)

Results publications

PMID 27658437, PMID 29674506, PMID 29958797, PMID 34724566